AF
DMAC icon

Allworth Financial’s DiaMedica Therapeutics DMAC Stock Holding History

Allworth Financial’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.7K Sell
8,057
-132
-2% -$811 ﹤0.01% 2373
2026
Q1 		$55.4K Buy
8,189
+8,088
+8,008% +$64.1K ﹤0.01% 2243
2025
Q4 		$804 Buy
101
+16
+19% +$120 ﹤0.01% 4419
2025
Q3 		$584 Buy
+85
New +$461 ﹤0.01% 4395

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allworth Financial's DMAC Position: Q2 2026 in Review

Allworth Financial reduced its DiaMedica Therapeutics (DMAC) stake by 1.6% in Q2 2026, selling an estimated $811 and leaving 8,057 shares worth $56.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2373.

Allworth Financial first reported a position in DMAC in Q3 2025 and has held it in 4 quarters since. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Allworth Financial held 8,057 shares of DiaMedica Therapeutics worth $56.7K as of Q2 2026.
  • Allworth Financial sold 132 DiaMedica Therapeutics shares in Q2 2026, an estimated $811.
  • DiaMedica Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2373 holding.
  • Allworth Financial first reported a position in DiaMedica Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.